Almirall Goes All In On Generative AI

Dermatology-focused Almirall S.A. is partnering with Microsoft for generative artificial intelligence capabilities. It is the second generative AI-based collaboration announced by Almirall in several months. 

Bio Bytes
• Source: Shutterstock

Barcelona-based Almirall SA is deepening its reliance on generative artificial intelligence (GenAI) for drug discovery and development. The company, which specializes in dermatological indications, entered a three-year collaboration with Microsoft to employ the big tech’s GenAI and advanced analytics capabilities to analyze datasets and strengthen its own technology platform.

Almirall’s CEO, Carlos Gallardo, was quoted in a press release as saying the partnership will “transform our ways of working...

More from Innovation

More from In Vivo